Exhibit 99.1 CLEARMIND MEDICINE INC. Condensed Interim Consolidated Financial Statements For The Three and Six Months Ended April 30, 2024 (Expressed in United States Dollars) (Unaudited) CLEARMIND MEDICINE INC. Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) (Unaudited) April 30, October 31, 2024 2023 Assets Current assets Cash and cash equivalents $8,305,927$ 5,427,739 Other receivables 69,506 104,320 Short-term investment (Note 3) – 86,112 Prepaid ex ...